Mar 28, 2018
PCMA Response to FDA Commissioner Scott Gottlieb's Remarks on the Drug Supply Chain
Mar 15, 2018
PCMA Responds to "Patient Right to Know Drug Prices Act"
Mar 07, 2018
PCMA Response to FDA Commissioner Scott Gottlieb's Remarks on Biosimilars
Feb 27, 2018
PCMA Supports Bipartisan E-Prescribing Legislation to Combat Opioid Epidemic
Feb 16, 2018
PCMA: CMS Report: PBM Tools Reduce Prescription Drug Costs
Feb 02, 2018
PCMA Applauds Administration's Effort to Reduce Opioid Abuse
Jan 04, 2018
Gleostine Price Hike Undercuts Drugmakers' Campaign to Deflect Blame for High Prices
Dec 13, 2017
PCMA Highlights How PBMs Reduce Costs and Improve Quality
Nov 30, 2017
New Drugmaker Lobby Report Attempts to Deflect Blame for Higher Prices
Nov 17, 2017
PCMA Statement on the CMS Medicare Part D Proposed Rule
Nov 07, 2017
PCMA Highlights PBM Solutions to Address the Opioid Crisis
Nov 01, 2017
PCMA Statement on the President's Commission on Combating Drug Addiction and the Opioid Crisis Report
Sep 11, 2017
AAM's Biosimilars Council Urges CMS to Revise Biosimilars Reimbursement Policy
Aug 08, 2017
PCMA Applauds the Administration's Effort to Combat the Opioid Crisis
Jul 19, 2017
PCMA Issues Guiding Principles, Policy Solutions to HHS on Reducing Prescription Drug Costs
Jul 12, 2017
PCMA Challenges North Dakota Health Mandates that Undermine Patient Safety, Increase Prescription Drug Costs
Jun 12, 2017
PCMA: Supreme Court Ruling on Biosimilars to Increase Competition, Reduce Drug Costs